InvestorsObserver
×
News Home

Is Cassava Sciences Inc (SAVA) a Bad Choice in Biotechnology Thursday?

Thursday, February 29, 2024 12:37 PM | InvestorsObserver Analysts

Mentioned in this article

Is Cassava Sciences Inc (SAVA) a Bad Choice in Biotechnology Thursday?

The 66 rating InvestorsObserver gives to Cassava Sciences Inc (SAVA) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 76 percent of stocks in the Biotechnology industry, SAVA’s 66 overall rating means the stock scores better than 66 percent of all stocks.

Overall Score - 66
SAVA has an Overall Score of 66. Find out what this means to you and get the rest of the rankings on SAVA!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Cassava Sciences Inc Stock Today?

Cassava Sciences Inc (SAVA) stock has fallen -0.35% while the S&P 500 is up 0.11% as of 12:37 PM on Thursday, Feb 29. SAVA has fallen -$0.08 from the previous closing price of $22.93 on volume of 192,691 shares. Over the past year the S&P 500 has risen 28.44% while SAVA has fallen -8.67%. SAVA lost -$2.29 per share the over the last 12 months. Click Here to get the full Stock Report for Cassava Sciences Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App